The Relationship between Weight as Well as the Kind of Prostate Hypertrophy and the Response to Tamsulosine, a Specific ?-Blocker

The Relationship between Weight as Well as the Kind of Prostate Hypertrophy and the Response to Tamsulosine, a Specific ?-Blocker

<p class="MsoNormal" style="margin: 0cm 0cm 0pt; direction: ltr; unicode-bidi: embed; text-align: left;"><span style="font-size: small;"><span style="font-family: Times New Roman;"><strong>Purpose:</strong> To study the effects of...

Full description

Bibliographic Details
Main Author:	Hayat Mombini
Format:	Article
Language:	English
Published:	Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences 2004-06-01
Series:	Urology Journal
Online Access:	http://www.urologyjournal.org/index.php/uj/article/view/341/335

Similar Items

Tamsulosin oral controlled absorption system (OCAS) in the treatment of benign prostatic hypertrophy
by: Mischel G Neill, et al.
Published: (2008-03-01)

Alpha blocker prazosin for the treatment of benign prostatic hypertrophy (BPH).
by: Punekar S, et al.
Published: (1995-10-01)

Add-on Therapy With the α-Blockers Tamsulosin and Naftopidil Improves Voiding Function by Enhancing Neuronal Activity in Prostatic Hyperplasia Rats
by: Il-Gyu Ko, et al.
Published: (2018-03-01)

A comparative study of fixed dose of Tamsulosin with finasteride vs Tamsulosin with dutasteride in the management of benign prostatic hyperplasia
by: N K Mohanty, et al.
Published: (2006-01-01)

Comparison of tamsulosin vs tamsulosin/sildenafil effectiveness in the treatment of erectile dysfunction in patients affected by type III chronic prostatitis
by: Ubaldo Cantoro, et al.
Published: (2013-09-01)

Meta-analysis of the efficacy and safety of combination of tamsulosin plus dutasteride compared with tamsulosin monotherapy in treating benign prostatic hyperplasia
by: Zhongbao Zhou, et al.
Published: (2019-03-01)

Combination therapy with dutasteride and tamsulosin for the treatment of symptomatic enlarged prostate
by: J Miller, et al.
Published: (2009-06-01)

Finasteride and Tamsulosin Combination in Benign Prostatic Enlargement in a Tertiary Hospital
by: Binod Bade Shrestha, et al.
Published: (2015-03-01)

Finasteride and Tamsulosin Combination in Benign Prostatic Enlargement in a Tertiary Hospital
by: Binod Bade Shrestha, et al.
Published: (2015-03-01)

Tamsulosin and Dementia in old age: is there any relationship?
by: Rebecca Renata Lapenda do Monte, Karina de Andrade Vidal Costa, Arnaldo Santiago Nunes Junior, Am lia Cinthia Meneses R go, Irami Ara jo Filho
Published: (2019-10-01)

‘Tamsulosin and Darifenacin’ Versus ‘Tamsulosin Monotherapy’ for ‘BPH with Accompanying Overactive Bladder’
by: IQBAL SINGH, et al.
Published: (2015-06-01)

Experience with the combination of dutasteride and tamsulosin in the long-term management of benign prostatic hyperplasia
by: Bilal Chughtai, et al.
Published: (2012-10-01)

Fixed-dose combination therapy with dutasteride and tamsulosin in the management of benign prostatic hyperplasia
by: Konstantinos Dimitropoulos, et al.
Published: (2016-02-01)

DETERMINATION OF TAMSULOSIN HYDROCHLORIDE RELEASE PHARMACOKINETICS IN PROSTATE GLAND BY A RADIOTRACER METHOD
by: V. I. Grytsenko, et al.
Published: (2013-10-01)

The mechanical properties of prostatic tissue : the relationship to morphology and the response to alpha blocker therapy
by: Leung, Steve Ken Wing
Published: (2013)

Relationship Between Expression of p53 Protein and Tumor Subtype and Grade in Renal Cell Carcinoma
by: Iran Rashidi, et al.
Published: (2006-03-01)

EFFICACY OF SELECTIVE ALPHA-1 RECEPTOR BLOCKERS (TAMSULOSIN) IN FACILITATING THE PASSAGE OF RENAL STONES AFTER EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY
by: Dr. Nauman Khalid, et al.
Published: (2021-02-01)

Comparison of With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis
by: Tong Cai, et al.
Published: (2020-04-01)

A comparison of the efficacy of naftopidil and tamsulosin hydrochloride in medical treatment of benign prostatic enlargement
by: Chenthil Perumal, et al.
Published: (2015-01-01)

A randomized comparative study of tamsulosin vs placebo in the treatment of benign prostatic hyperplasia
by: N K Mohanty, et al.
Published: (2003-01-01)

Tadalafil versus alpha blockers (alfuzosin, doxazosin, tamsulosin and silodosin) as medical expulsive therapy for < 10 mm distal and proximal ureteral stones
by: Serdar Çelik, et al.
Published: (2018-06-01)

Prophylactic effects of alpha-blockers, Tamsulosin and Alfuzosin, on postoperative urinary retention in male patients undergoing urologic surgery under spinal anaesthesia
by: Ali Akkoc, et al.
Published: (2016-06-01)

Prostate, benign hypertrophy and prostatic carcinoma - a study of cell biology of prostate and chemotherapy for prostatic hypertrophy and prostatic cancer /
by: Chang, Ching-Jey George
Published: (1994)

Prostate-Specific Antigen Density: A Measurement to Differentiate Benign Hypertrophy of Prostate from Prostate Carcinoma
by: Chandan Kumar Nath, et al.
Published: (2020-03-01)

Clinical significance of prostatic-urethral angulation on the treatment outcome of patients with symptomatic benign prostatic hyperplasia treated with tamsulosin hydrochloride
by: Hassan El-Tatawy, et al.
Published: (2015-09-01)

Does the addition of Serenoa repens to tamsulosin improve its therapeutical efficacy in benign prostatic hyperplasia?
by: Argirović Aleksandar, et al.
Published: (2013-01-01)

Short-term effect of tamsulosin and finasteride monotherapy and their combination on nigerian men with benign prostatic hyperplasia
by: Benjamin O Odusanya, et al.
Published: (2017-01-01)

The Effect of Oral Tamsulosin vs. Oral Tamsulosin and Oral Isosorbide Dinitrate in Acute Urinary Retention Patients Due to Benign Prostatic Hyperplasia: A Double-Blind Clinical Trial Study
by: Iraj Golikhatir, et al.
Published: (2020-06-01)

Effects of renin-angiotensin system blockers on left ventricular hypertrophy and biochemical markers of collagen balance in patients with hypertensive hypertrophy
by: A G Ovchinnikov, et al.
Published: (2009-05-01)

Original and generic Tamsulosin: is there a difference?
by: SK Zyryanov, et al.
Published: (2014-12-01)

The efficacy of tamsulosin in lower ureteral calculi
by: Griwan M, et al.
Published: (2010-01-01)

TREATMENT WITH TAMSULOSIN IN PATIENTS WITH DISTAL URETERALCALCULI
by: Klemen Jagodič, et al.
Published: (2008-12-01)

Screening for benign prostatic hypertrophy
by: Tsang, K. K.
Published: (1995)

High sympathetic tone in development of the left ventricle hypertrophy and beta-blockers for regression
by: О. D. Ostroumova, et al.
Published: (2018-09-01)

β-AR blockers suppresses ER stress in cardiac hypertrophy and heart failure.
by: Li Ni, et al.
Published: (2011-01-01)

EFFECTIVENESS AND SAFETY OF THE «DE ALEX» BIO COMPLEX AS MONOTHERAPY AND IN COMBINATION WITH TAMSULOSIN IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
by: P. A. Scheplev, et al.
Published: (2017-11-01)

Comparative evaluation of naftopidil and tamsulosin in the treatment of patients with lower urinary tract symptoms with benign prostatic hyperplasia
by: Mahavir Singh Griwan, et al.
Published: (2014-01-01)

Additive effect of oral LDD175 to tamsulosin and finasteride in a benign prostate hyperplasia rat model
by: Choi BR, et al.
Published: (2018-06-01)

Effect of dutasteride on prostate biopsy rates and the diagnosis of prostate cancer in men with lower urinary tract symptoms and enlarged prostates in the combination of avodart and tamsulosin trial
by: Andreas Bohle
Published: (2011-04-01)

Evidence Is Enough?: A Systematic Review and Network Meta-Analysis of the Efficacy of Tamsulosin 0.2 mg and Tamsulosin 0.4 mg as an Initial Therapeutic Dose in Asian Benign Prostatic Hyperplasia Patients
by: Su Jin Kim, et al.
Published: (2017-03-01)

Cannot write session to /tmp/vufind_sessions/sess_jfsufu85rp0pkgjnl78ht58ccc